Sidley Lawyer Michael Borden To Speak on “The Biosecure Act: What Chinese Biotech and Life Sciences Companies Need To Know” Webinar

Tune in as Sidley partner Michael Borden joins BioSeedin’s upcoming webinar, “The BIOSECURE Act: What Chinese Biotech and Life Sciences Companies Need to Know”. The session will explore the scope of the prohibitions, how Chinese firms are designated under the new law, and steps to minimize exposure (more on the Act’s inclusion in the FY26 National Defense Authorization here). Bioseedin is a leading advisory firm for biotech and pharmaceutical companies in the Asia Pacific region.